risperidone has been researched along with clonazepam in 28 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (10.71) | 18.2507 |
| 2000's | 11 (39.29) | 29.6817 |
| 2010's | 13 (46.43) | 24.3611 |
| 2020's | 1 (3.57) | 2.80 |
| Authors | Studies |
|---|---|
| Topliss, JG; Yoshida, F | 1 |
| Andricopulo, AD; Moda, TL; Montanari, CA | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
| Alelyunas, YW; Bui, K; Empfield, JR; McCarthy, D; Pelosi-Kilby, L; Shen, C; Spreen, RC | 1 |
| Chen, B; Huang, L; Song, J; Yin, L; Zhang, W; Zhang, X | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Finlayson, R; Jones, BD; Labelle, A; Purdon, SE | 1 |
| Zimbroff, DL | 1 |
| Bharwani, I; Penetrante, AE; Raheja, RK | 1 |
| Abdelhamid, A; Annandale, JB; Lauterbach, EC | 1 |
| Bassitt, DP; de Souza Lobo Garcia, L | 1 |
| Kasper, S; Letmaier, M; Schreinzer, D; Wolf, R | 1 |
| Fong, SY; Lam, MH; Wing, YK | 1 |
| Jebaraj, P; Rajkumar, AP; Tharyan, P | 1 |
| Inada, T; Oda, T; Yamamoto, N | 1 |
| Shen, YC | 1 |
| Arroyo Plasencia, AM; Ballentine, LM; Kao, LW; Mowry, JB | 1 |
| Balas, I; Fekete, S; Janszky, J; Komoly, S; Kovacs, N; Simon, M | 1 |
| Fajardo, K; Grenier, E; John, V; Ko, E; Ryan, M | 1 |
| Chen, H; Fang, M; Huang, J; Li, LH; Li, Y; Liu, L; Wang, B; Wang, G; Wu, R; Ye, M; Zhang, L; Zhang, Q; Zhao, JP; Zheng, H; Zhou, J; Zhu, S | 1 |
| Ferencz, C; Fullajtar, M | 1 |
| Askenazy, F; Drici, M; Lavrut, T; Menard, ML; Yagoubi, F | 1 |
| Hallahan, B; Murphy, RA | 1 |
| Ambaliya, A; Dosi, R; Joshi, H; Patell, R | 1 |
| Dwivedi, S; Kar, SK | 1 |
| Acheampong, D; Cardieri, B; Coffey, BJ; Crow, M; Rice, T | 1 |
2 review(s) available for risperidone and clonazepam
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Serotonin syndrome versus neuroleptic malignant syndrome: a challenging clinical quandary.
Topics: Antimanic Agents; Antipsychotic Agents; Benzodiazepines; Clonazepam; Diagnosis, Differential; GABA Modulators; Humans; Lithium Compounds; Male; Neuroleptic Malignant Syndrome; Olanzapine; Risperidone; Serotonin Syndrome; Valproic Acid; Young Adult | 2014 |
1 trial(s) available for risperidone and clonazepam
| Article | Year |
|---|---|
Comparison of risperidone oral solution and intramuscular haloperidol with the latter shifting to oral therapy for the treatment of acute agitation in patients with schizophrenia.
Topics: Administration, Oral; Adult; Akathisia, Drug-Induced; Antipsychotic Agents; China; Clonazepam; Diagnostic and Statistical Manual of Mental Disorders; Drug Monitoring; Drug Therapy, Combination; Female; Haloperidol; Humans; Hypnotics and Sedatives; Injections, Intramuscular; Male; Psychomotor Agitation; Risperidone; Schizophrenia; Severity of Illness Index; Young Adult | 2012 |
25 other study(ies) available for risperidone and clonazepam
| Article | Year |
|---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Hologram QSAR model for the prediction of human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2007 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Experimental solubility profiling of marketed CNS drugs, exploring solubility limit of CNS discovery candidate.
Topics: Central Nervous System Agents; Drug Evaluation, Preclinical; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Solubility | 2010 |
Synthesis and pharmacological evaluation of piperidine (piperazine)-substituted benzoxazole derivatives as multi-target antipsychotics.
Topics: Animals; Antipsychotic Agents; Ether-A-Go-Go Potassium Channels; Humans; Mice; Oxazoles; Patch-Clamp Techniques; Piperazines; Piperidines; Potassium Channel Blockers; Rats; Receptors, Dopamine D2; Schizophrenia; Serotonin 5-HT1 Receptor Agonists; Serotonin 5-HT2 Receptor Agonists; Structure-Activity Relationship; Swine | 2015 |
Risperidone treatment for severe negative symptoms.
Topics: Adult; Antipsychotic Agents; Clonazepam; Depressive Disorder; Drug Therapy, Combination; Humans; Isoxazoles; Male; Patient Readmission; Piperidines; Risperidone; Schizophrenia; Schizophrenic Psychology | 1994 |
Switching patients from clozapine to risperidone therapy.
Topics: Antipsychotic Agents; Clonazepam; Clozapine; Drug Administration Schedule; Drug Therapy, Combination; Humans; Isoxazoles; Lorazepam; Piperidines; Risperidone; Schizophrenia; Substance Withdrawal Syndrome | 1995 |
Efficacy of risperidone for behavioral disorders in the elderly: a clinical observation.
Topics: Aged; Antipsychotic Agents; Clonazepam; Dose-Response Relationship, Drug; Drug Therapy, Combination; Humans; Hypotension, Orthostatic; Male; Mental Disorders; Psychomotor Agitation; Risperidone; Treatment Outcome | 1995 |
Posthallucinogen-like visual illusions (palinopsia) with risperidone in a patient without previous hallucinogen exposure: possible relation to serotonin 5HT2a receptor blockade.
Topics: Antidepressive Agents, Second-Generation; Antipsychotic Agents; Bipolar Disorder; Clonazepam; Female; GABA Modulators; Humans; Illusions; Middle Aged; Receptor, Serotonin, 5-HT2A; Receptors, Serotonin; Risperidone; Serotonin Antagonists; Trazodone | 2000 |
Risperidone-induced tardive dyskinesia.
Topics: Adult; Anti-Dyskinesia Agents; Antipsychotic Agents; Biperiden; Blepharospasm; Botulinum Toxins; Clonazepam; Dyskinesia, Drug-Induced; Electroencephalography; Humans; Male; Risperidone; Schizophrenia, Paranoid | 2000 |
Topiramate as a mood stabilizer.
Topics: Acute Disease; Adaptation, Psychological; Adult; Antimanic Agents; Bipolar Disorder; Clonazepam; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Fructose; Humans; Life Change Events; Patient Readmission; Recurrence; Risperidone; Topiramate | 2001 |
Sexual disinhibition in schizophrenia possibly induced by risperidone and quetiapine.
Topics: Adult; Antimanic Agents; Antipsychotic Agents; Clonazepam; Dibenzothiazepines; Female; GABA Modulators; Gonadal Steroid Hormones; Humans; Masturbation; Quetiapine Fumarate; Risperidone; Schizophrenia; Schizophrenic Psychology; Sexual Behavior; Sexual Dysfunctions, Psychological; Valproic Acid | 2007 |
Multi-drug overdose risperidone, ziprasidone, valproate, trihexyphenidyl, and clonazepam.
Topics: Adult; Antipsychotic Agents; Clonazepam; Drug Overdose; Drug Prescriptions; Female; Humans; Piperazines; Polypharmacy; Risperidone; Schizophrenia, Paranoid; Thiazoles; Trihexyphenidyl; Valproic Acid | 2007 |
Methamphetamine psychosis in which tardive dystonia was successfully treated with clonazepam.
Topics: Aged; Anti-Dyskinesia Agents; Antipsychotic Agents; Benzodiazepines; Biperiden; Central Nervous System Stimulants; Clonazepam; Dyskinesia, Drug-Induced; Hallucinations; Haloperidol; Humans; Male; Methamphetamine; Olanzapine; Posture; Psychoses, Substance-Induced; Risperidone | 2007 |
Unilateral rubral tremor following treatment with risperidone.
Topics: Anticonvulsants; Antipsychotic Agents; Ataxia; Behavior Therapy; Bipolar Disorder; Brain; Carbamazepine; Clonazepam; Combined Modality Therapy; Dose-Response Relationship, Drug; Drug Therapy, Combination; Humans; Magnetic Resonance Imaging; Male; Mesencephalon; Neural Pathways; Neurologic Examination; Red Nucleus; Risperidone; Valproic Acid; Young Adult | 2009 |
Benzodiazepine-associated atrioventricular block.
Topics: Acetaminophen; Alprazolam; Anti-Anxiety Agents; Anticonvulsants; Antidotes; Atrioventricular Block; Child, Preschool; Clonazepam; Drug Combinations; Electrocardiography; Flumazenil; Humans; Hydrocodone; Male; Risperidone; Young Adult | 2012 |
Status dystonicus in tardive dystonia successfully treated by bilateral deep brain stimulation.
Topics: Adolescent; Antipsychotic Agents; Clonazepam; Deep Brain Stimulation; Disability Evaluation; Electrodes, Implanted; GABA Modulators; Globus Pallidus; Humans; Hyperkinesis; Hypnotics and Sedatives; Male; Midazolam; Movement Disorders; Neurosurgical Procedures; Risperidone; Schizophrenia | 2011 |
Risperidone and lorazepam concomitant use in clonazepam refractory catatonia: a case report.
Topics: Catatonia; Clonazepam; Drug Therapy, Combination; Female; Humans; Lorazepam; Risperidone; Young Adult | 2011 |
[Designer drug induced psychosis].
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Benzodioxoles; Clonazepam; Designer Drugs; Drug Therapy, Combination; Humans; Hungary; Male; Olanzapine; Psychoses, Substance-Induced; Psychotropic Drugs; Pyrrolidines; Risperidone; Substance Abuse Detection; Synthetic Cathinone | 2012 |
[Follow-up of a 16-year-old adolescent with early-onset schizophrenia and catatonic symptoms].
Topics: Adolescent; Benzodiazepines; Carbamazepine; Clonazepam; Clozapine; Creatine Kinase; Diagnosis, Differential; Drug Resistance; Drug Substitution; Drug Therapy, Combination; Humans; Lorazepam; Male; Olanzapine; Patient Admission; Psychiatric Status Rating Scales; Psychometrics; Recurrence; Risperidone; Schizophrenia, Catatonic | 2013 |
Psychosis improved dysphonia.
Topics: Acute Disease; Adult; Anti-Anxiety Agents; Antipsychotic Agents; Clonazepam; Diagnosis, Differential; Dysphonia; Humans; Male; Psychotic Disorders; Recurrence; Remission, Spontaneous; Risperidone; Treatment Outcome | 2013 |
Alcohol binge drinking in OCD: A compulsive ritualistic behaviour to counter magical thinking.
Topics: Adult; Antipsychotic Agents; Binge Drinking; Ceremonial Behavior; Clonazepam; Cognitive Behavioral Therapy; Compulsive Behavior; Fluvoxamine; GABA Modulators; Humans; Magic; Male; Obsessive-Compulsive Disorder; Risperidone; Selective Serotonin Reuptake Inhibitors | 2017 |
High-Dose Benzodiazepines in Treatment of Malignant Catatonia in an Adolescent: Lorazepam, Clonazepam, and Differing Efficacy.
Topics: Adolescent; Anticonvulsants; Catatonia; Clonazepam; Humans; Lorazepam; Male; Risperidone; Treatment Outcome | 2021 |